Nab-paclitaxel-based chemotherapy with or without anti-PD-(L)1 immunotherapy as a second-line treatment for advanced biliary tract cancer: a real-world retrospective study
以白蛋白结合型紫杉醇为基础的化疗联合或不联合抗PD-(L)1免疫疗法作为晚期胆道癌二线治疗:一项真实世界回顾性研究
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251389753
Zhou, Nan; Li, Xinyi; Gao, Mingyou; Li, Xiaofen; Tan, Sirui; Hu, Qiancheng; Lu, Zijian; Xiao, Xi; Wang, Tianhong; Zhang, Shunyu; Luo, Haiyan; Yi, Cheng; Yang, Yu; Gou, Hongfeng